Calibre What Science Can Do
This website contains promotional content about AstraZeneca Medications. This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.
Bite size education on key cardiology topics
Jan has had a very long and rewarding career at Liverpool Heart and Chest Hospital for 33 years in various roles within both the cardiology and surgical directorates.
From 2008-2018, Jan was the Lead Nurse for Cardiac Rehabilitation and health promotion and after implementing many successful initiatives, notably improving patient’s referral pathways she stepped down to concentrate on her current role.
Jan is currently the Lead Nurse for Cardiovascular disease prevention for the Cheshire & Merseyside CVD programme Board where she leads on a range of work streams that include alcohol, smoking, sugar, lipids and cardiac rehabilitation.
Since 2013, Jan has been the chair for the Cheshire & Merseyside CR practitioner’s group –this group meets quarterly to share best practice and provides education and peers support and is an excellent platform to drive and influence local and national policies and guidelines to improve all our service delivery models.
Jan also a practitioner with a special interest in Cardiology and graduated from Bradford University in December 2017. Her other job roles within the Trust include lead responsibility for the alcohol and smoking CQUIN, making every contact count and staff health and wellbeing.
When Jan is not working, she loves spending many hours on long walks across the Wirral with her husband Paul, her grown up children Heather and Adam and her two little dogs Bowes and Bailey. Jan also enjoys family holidays together, visiting the cinema, dining out and dancing at Zumba classes.
Jan is passionate about prevention and ensuring patients are at the heart of everything she does ensuring partnership working, benchmarking, sharing best practice and collaboration are integral to ensure our success and improve patient outcomes and is happy to share her knowledge and experiences with stakeholders.
If you would like more information, please feel free to contact Jan Naybour by email Jan.Naybour@lhch.nhs.uk
The high-risk post-myocardial infarction (MI) patient pathway
Dr Yahya Al-Najjar
Dr Yahya Al-Najjar
Dr Al-Najjar graduated from the University of Manchester. He trained in Cardiology in the North West region. He has a special interest in acute cardiovascular care and has been involved in multiple projects to improve the care of patients presenting to hospital with cardiac conditions. He was heavily involved in redesigning the model of care for cardiac patients presenting to Blackpool Victoria Hospital resulting in a reduction in length of stay. He is an enthusiastic teacher and a keen supporter of the use of simulation suites to provide interactive teaching to medical students and junior doctors. His specialist interests include complex coronary intervention, and the management of coronary artery disease and heart failure. Hobbies include playing tennis and soccer.
The management of high-risk* post-myocardial infarction (MI) patients transitioning from secondary to primary care
Professor Ahmet Fuat
Prof Ahmet Fuat
Professor Ahmet Fuat has been a GP in Darlington, Co.Durham for 33 years. He has been a GPSI Cardiology for 20 years having undertaken a Postgraduate Diploma in Cardiology at Bradford University graduating with distinction. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 17 years ago with local colleagues. His PhD by research in heart failure diagnosis and management including work on natriuretic peptides generated several publications that have informed guidelines and led to the award of an Honorary Professorial Chair at Durham University.
He holds various roles in CVD and research including the elected President of the new Primary Care Cardiovascular Society (PCCS) which he was instrumental in reforming, CVD Clinical Adviser to the RCGP, CVD and Research Leads for Darlington PCN and Federation, Associate Lead for Industry Research at North East and North Cumbria NIHR CRN.
He has a passion for medical education and remains an active lecturer, tutor and researcher. He is on the editorial boards of the British Journal of Cardiology and Primary Care Cardiovascular journal and a peer reviewer for most high impact cardiovascular journals and research bodies. His work in community cardiology has been recognised with fellowships from the RCGP, RCP London and RCP Edinburgh.
The value of risk scores for assessing the role of long-term dual antiplatelet therapy (DAPT) in non-ST-elevation myocardial infarction (NSTEMI) patients
Prof Anthony Gershlick
Prof Anthony Gershlick
Consultant cardiologist since 1989. Made Professor of Interventional Cardiology at University of Leicester 2008. Major interest has been in acute cardiology and intervention for coronary artery disease. Was the first in the UK to undertake clinical brachytherapy, the first to implant a drug eluting stent and the first to treat a patient in the UK with stem cells from the leg muscle and the first to implant a bio-absorbable stent.
Lead faculty for multiple major International meetings. Research interests over the years have covered the basic science/pre-clinical area as well as the application of proven basic concepts as applied to and assessed in the clinical arena. “Since the early 1990s lab has investigated ways of delivering drugs loaded onto the stents themselves in order to reduce the unwanted tissue response. In 1996 Prof Gershlick published a benchmark pre-clinical study in Circulation that demonstrated the efficacy of drugs delivered locally in this way. Current pre-clinical projects include assessing whether loading of stents with HIF- (a growth factor switch molecule) for treating difficult CTOs. He devised, ran and analysed the REACT trial and was co-Principal Investigator of the New England Journal of Medicine published STREAM trial.
Continuous care and treatment management for non-ST-elevated myocardial infarction (NSTEMI) patients
Dr Nick Pegge & Dr Emmanuel Ako
Dr. Nick Pegge
Qualified from Jesus College, Cambridge and St Thomas', London.
Postgraduate training at Royal Sussex County Hospital, Brighton; Royal Free Hospital and St George's Hospital, London; Singleton and Morriston Hospitals, Swansea; University Hospital of Wales, Cardiff.
Fellowship in Interventional Cardiology, University Hospital, Frankfurt am Main, Germany (2003).
Professional interests: all forms of cardiology, especially coronary intervention, heart failure, arrhythmias, pacing and complex device therapy.
Expert witness for GMC.
Chair of Trust Joint Private Practice Committee.
Professional memberships: British Cardiovascular Society, British Cardiovascular Intervention Society, European Society of Cardiology.
Dr. Emmanuel Ako
Dr Emmanuel Ako is a Consultant Cardiologist with a specialist interest in Coronary Intervention and the treatment of coronary artery disease. He also has expertise in cardiovascular complications in haemoglobinopathies such as thalassaemia and sickle cell disease. He works at both Chelsea and Westminster NHS Foundation Trustand the Royal Brompton Hospital NHS Trust, London, UK
He studied medicine at University College London, UK, where he graduated with distinction in 2005 and awarded several prizes including an award from the Vandervell foundation, PPP foundation and NIHR.
He completed an intercalated BSc in Physiology supported by the prestigious award from the Physiological society achieving a 1st -class honours. He completed his postgraduate medical training at St George's, The London Chest and the Heart Hospital in London. He achieved his MRCP before dual accrediting in general internal medicine and cardiology in North East Thames. He trained in interventional cardiology at the Heart Hospital and Barts Heart Centre. Dr Ako gained complimentary training in cardiac MRI and Cardiac CT at Great Ormond Street and Barts Heart Centre.
In addition to his clinical commitments, Dr Ako has been involved in stem cell research for ischaemic heart disease and the effects of thalassemia and sickle cell disease on the cardiovascular system. He has an interest in cardiac MRI focusing on its use in pulmonary hypertension in haemoglobinopathies. He is a winner of the American College of Cardiology Young Investigator Award for research into haemoglobinopathy and a finalist at the SCMR Early Career Awards in Los Angeles and the RSM Presidents Medal in London.
Dr Ako is active in clinical education and research. He also has expertise in simulation based training in cardiology. He has been involved in developing a very successful simulation based training programme with Imperial College London, which has been rolled out across the UK aimed at cardiologists and anaesthetists.
Dr Ako has published various articles, presented at national and international conferences and is a frequent speaker in public engagement workshops internationally.